Last updated: August 1, 2023
Sponsor: Massachusetts General Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Urologic Cancer
Stomach Cancer
Lung Cancer
Treatment
Virtual Cancer and Mental Health Tumor Board
Clinical Study ID
NCT05837598
22-593
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years old
- Verbal fluency in English
- SMI (schizophrenia spectrum disorder, bipolar disorder, or major depressive disorderwith either prior psychiatric hospitalization, history of suicide attempt/suicidalideation, Medicaid insurance, and/or comorbid alcohol or opioid use disorder)confirmed by diagnostic evaluation of study psychiatrist
- New invasive stage I-IV breast, lung, gastrointestinal, genitourinary, or head andneck cancer (highly suspected or confirmed according to documentation by theoncologist or pathology)
- Oncology consultation at or referral to a MGH Danvers within the past 8 weeks
Exclusion
Exclusion Criteria:
- Have cognitive impairment severe enough to interfere with completing brief studyassessments or providing informed consent and does not have a guardian who can provideconsent
- Recurrence of same cancer type
- Do not have verbal fluency in English
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Virtual Cancer and Mental Health Tumor Board
Phase:
Study Start date:
May 31, 2023
Estimated Completion Date:
May 31, 2024
Study Description
Connect with a study center
Mass General/North Shore Center for Outpatient Care
Danvers, Massachusetts 01923
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.